Results 151 to 160 of about 2,084 (194)
Minimally invasive trabecular meshwork surgery for open-angle glaucoma. [PDF]
Cochrane Database Syst RevVemulapalli K +7 more
europepmc +1 more source
Comparison of the iStent Inject® Versus the iStent Inject® W—Both in Combination With Cataract Surgery—In Open-Angle Glaucoma [PDF]
Journal of Clinical Medicine, 2023 We compare the short- and mid-term postoperative outcomes of the iStent inject® with its successor, the iStent inject® W. A retrospective monocentric study was performed to compare the iStent inject® used for cataract surgery with the iStent inject® W, also used for cataract surgery.
Nicole Eter +2 more
exaly +6 more sources
Minimally Invasive Glaucoma Surgery: Comparison of iStent With iStent Inject in Primary Open Angle Glaucoma [PDF]
Clinical and Experimental Ophthalmology, 2019 Importance: Minimally invasive glaucoma surgery has gained significant traction in recent years. This study evaluates the first‐ and second‐generation trabecular micro‐bypass stents “iStent” and “iStent inject”.
Nathan M Kerr +2 more
exaly +3 more sources
One-Year Comparative Evaluation of iStent or iStent Inject Implantation Combined With Cataract Surgery in a Single Center [PDF]
Advances in Therapy, 2019 This retrospective consecutive case series assessed 12-month effectiveness and safety of iStent® or iStent inject® trabecular micro-bypass implants with cataract surgery in patients with open-angle glaucoma (OAG) in a real-world clinical setting.Effectiveness outcomes consisted of intraocular pressure (IOP) reduction; glaucoma medication reduction ...
Alfredo Chaoubah +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
iStent inject: comprehensive review
Journal of Cataract & Refractive Surgery, 2021Microinvasive glaucoma surgeries (MIGSs) are new surgical procedures for treatment of glaucoma. They aim to safely and effectively reduce intraocular pressure (IOP) with minimal trauma to the eye and less complications. The first-generation iStent is the first approved ab interno MIGS implant for management of open-angle glaucoma.
Wesam Shamseldin, Shalaby +3 more
openaire +2 more sources
Journal of Clinical Medicine, 2021 Glaucoma is the leading cause of irreversible blindness worldwide. The only proven factor in slowing the progression of glaucomatous neuropathy is lower intraocular pressure (IOP), which can be achieved with pharmacology, laser therapy, or surgery ...
Kinga Gołaszewska +2 more
exaly +2 more sources
Managing coexistent cataract and glaucoma with iStent
Survey of Ophthalmology, 2017The iStent is an intraocular implant that resides within Schlemm canal and allows for direct bypass of the trabecular meshwork by aqueous fluid. It is one of several procedures termed microinvasive glaucoma surgery. The prominence of microinvasive glaucoma surgery is growing because of its role in lowering intraocular pressure in mild to moderate ...
Christine L. Larsen, Thomas W. Samuelson
openaire +2 more sources
The iStent® MIGS Family: iStent®, iStent Inject®, and iStent Supra®
2013Microinvasive glaucoma surgeries or MIGS, an acronym coined by Ike Ahmed, represents a fundamental shift in glaucoma surgical philosophy. MIGS exploit existing physiologic outflow pathways allowing both rapid placement and visual recovery. The surgeon interacts with small anatomic functional structures in a minimally destructive manner.
Richard A. Hill +2 more
openaire +1 more source
Rothia Mucilaginosa Endophthalmitis Associated With iStent Inject Implantation
Journal of Glaucoma, 2022Postoperative endophthalmitis caused by Rothia mucilaginosa, a gram-positive, coagulase-negative Micrococcaceae of the oropharyngeal flora, is rare and all previously reported intraocular implant-related cases have resulted in evisceration. R. mucilaginosa endophthalmitis has also not been described with any glaucoma implant device.
Helena, Lam +3 more
openaire +2 more sources
Acta Ophthalmologica, 2013
Abstractistent is a novel device that canulates Schlemms canal to enhance physiological outflow and lowers intraocular pressure. Results of istent surgery combined with phaco would be presented, together with the results of intraoperative flow test. Results of multiple istents and istent Supra would also be presented.
openaire +1 more source
Abstractistent is a novel device that canulates Schlemms canal to enhance physiological outflow and lowers intraocular pressure. Results of istent surgery combined with phaco would be presented, together with the results of intraoperative flow test. Results of multiple istents and istent Supra would also be presented.
openaire +1 more source